...
首页> 外文期刊>Journal of Clinical Pharmacy and Therapeutics >Rapid i.v. loading with phenytoin with subsequent dose adaptation using non-steady-state serum levels and a Bayesian forecasting computer program to predict maintenance doses.
【24h】

Rapid i.v. loading with phenytoin with subsequent dose adaptation using non-steady-state serum levels and a Bayesian forecasting computer program to predict maintenance doses.

机译:快速i.v.服用苯妥英钠,随后使用非稳态血清水平和贝叶斯预测计算机程序对剂量进行调整,以预测维持剂量。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: To evaluate the suitability of a phenytoin loading dose regimen; to assess whether dose-individualization was necessary and to investigate the reliability of a Bayesian forecasting method for phenytoin dose adaptation using non-steady-state levels in hospital-admitted patients. METHOD: An initial loading dose (15 mg phenytoin acid/kg BW) was given i.v. over 4 h, followed by standardized maintenance doses given i.v. in 12-h intervals from days 1 to 5 (175 mg 70 kg BW). The evening dose of day 5 was individualized based on three serum trough levels: L1 (after 16 h), L2 (morning day 4) and L3 (morning day 5). RESULTS: Ninety of 136 consecutive patients were evaluable in a prospective study for the standardized phase; 50 of them had additional serum levels in the individualized phase. There was no exclusion of patients with interacting co-medication. Seventy-seven per cent (L1) and 68% (L3) of patients showed therapeutic values (10-20 mg/L). The prediction error of the forecasting was 3.95 mg/L, the root mean squared error 6.27 mg/L (target trough level 11 mg/L). Seventy per cent of the levels (n=50) were within the 68% confidence interval. CONCLUSION: The effectiveness and safety of the regimen with rapid i.v. loading and the necessity to individualize phenytoin dosing after day 5 were demonstrated.
机译:目的:评估苯妥英钠负荷剂量方案的适用性;评估是否需要个体化剂量,并研究在医院允许的患者中使用非稳态水平进行苯妥英钠剂量适应的贝叶斯预测方法的可靠性。方法:静脉内给予初始负荷剂量(15 mg苯妥英酸/ kg BW)。超过4小时,然后静脉给予标准维持剂量。从第1天到第5天间隔12小时(175毫克 70千克体重)。第5天的夜间剂量根据三个血清谷水平进行个性化设置:L1(16小时后),L2(早晨4天)和L3(早晨5天)。结果:136名连续患者中有90名在标准化阶段的前瞻性研究中得到了评估。其中有50个个体化阶段的血清水平更高。没有排除相互作用的联合用药的患者。 77%(L1)和68%(L3)的患者显示出治疗价值(10-20 mg / L)。预测的预测误差为3.95 mg / L,均方根误差为6.27 mg / L(目标谷值11 mg / L)。 70%的水平(n = 50)在68%的置信区间内。结论:快速静脉输注该方案的有效性和安全性。证明了第5天后的负荷量和个体化苯妥英钠剂量的必要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号